Autophagic marker MAP1LC3B expression levels are associated with carotid atherosclerosis symptomatology

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Swaminathan, Bhairavi ^a   Goikuria, Haize ^a,c   Vega, Reyes ^d   Rodríguez Antigüedad, Alfredo ^d   López Medina, Antonio ^d   Del Mar Freijo, María ^d   Vandenbroeck, Koen ^a,b,c   Alloza, Iraide ^a,b,c  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b BASQUE FOUNDATION FOR SCIENCE   (Spain)

^c ACHUCARRO BASQUE CENTER FOR NEUROSCIENCE   (Spain)

^d HOSPITAL DE BASURTO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 12P40; BIOLOGICAL MARKER; MAP1LC3B PROTEIN, HUMAN; MICROTUBULE ASSOCIATED PROTEIN;

AGED; ARTICLE; ASYMPTOMATIC DISEASE; ATHEROSCLEROTIC PLAQUE; AUTOPHAGY; CAROTID ATHEROSCLEROSIS; ERO1LB GENE; ERP27 GENE; EVA1A GENE; FEMALE; GENE; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; IL12B GENE; ITPR1 GENE; MAJOR CLINICAL STUDY; MALE; MAP1LC3B GENE; RAB24 GENE; SYMPTOMATOLOGY; TIMP1 GENE; BIOSYNTHESIS; CAROTID ARTERY DISEASE; CAROTID ARTERY OBSTRUCTION; GENETIC ASSOCIATION STUDY; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY;

AGED; AUTOPHAGY; BIOMARKERS; CAROTID ARTERY DISEASES; CAROTID STENOSIS; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION STUDIES; HUMANS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; PLAQUE, ATHEROSCLEROTIC;

EID: 84918838918     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0115176     Document Type: Article

References (50)

1. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, et al. (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet 380: 2095-2128. DOI: 10.1016/S0140-6736(12)61728-0.
2. Murray CJL, Vos T, Lozano R, Naghavi M, Flaxman AD, et al. (2012) Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet 380: 2197-2223. DOI: 10.1016/S0140-6736(12)61689-4.
3. Walker MD, Marler JR, Goldstein M, Grady PA, Toole JF, et al. (1995) Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995; 273: 1421-1428. DOI: 10.1001/jama.1995.03520420037035.
4. Golledge J, Greenhalgh RM, Davies AH (2000) The Symptomatic Carotid Plaque. Stroke 31: 774-781. DOI: 10.1161/01.STR.31.3.774.
5. NASCET C (1991) Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. New Engl J Med 325: 445-453. DOI: 10.1056/NEJM199108153250701.
6. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, et al. (2003) From Vulnerable Plaque to Vulnerable Patient: A Call for New Definitions and Risk Assessment Strategies: Part I. Circulation 108: 1664-1672. DOI: 10.1161/01.CIR.0000087480.94275.97
7. Morgan AR, Rerkasem K, Gallagher PJ, Zhang B, Morris GE, et al. (2004) Differences in Matrix Metalloproteinase-1 and Matrix Metalloproteinase-12 Transcript Levels Among Carotid Atherosclerotic Plaques With Different Histopathological Characteristics. Stroke 35: 1310-1315. DOI: 10.1161/01.STR.0000126822.01756.99.
8. Ijäs P, Nuotio K, Saksi J, Soinne L, Saimanen E, et al. (2007) Microarray analysis reveals overexpression of CD163 and HO-1 in symptomatic carotid plaques. Arterioscl Throm Vasc Biol 27: 154-160. DOI: 10.1161/01.ATV.0000251991.64617.e7.
9. Papaspyridonos M, Smith A, Burnand KG, Taylor P, Padayachee S, et al. (2006) Novel Candidate Genes in Unstable Areas of Human Atherosclerotic Plaques. Arterioscl Throm Vasc Biol 26: 1837-1844. DOI: 10.1161/01.ATV.0000229695.68416.76.
10. Erbel C, Dengler T, Wangler S, Lasitschka F, Bea F, et al. (2011) Expression of IL-17A in human atherosclerotic lesions is associated with increased inflammation and plaque vulnerability. Basic Res Cardiol 106: 125-134. DOI: 10.1007/s00395-010-0135-y.
11. Saksi J, Ijäs P, Nuotio K, Sonninen R, Soinne L, et al. (2011) Gene expression differences between stroke-associated and asymptomatic carotid plaques. J Mol Med 89: 1015-1026. DOI: 10.1007/s00109-011-0773-z.
12. Ley K, Huo Y (2001) VCAM-1 is critical in atherosclerosis. J Clin Invest 107: 1209-1210. DOI: 10.1172/JCI13005.
13. Kowala MC (1997) The role of endothelin in the pathogenesis of atherosclerosis. Adv Pharmacol 37: 299-318.
14. Rekhter MD (2014) Collagen synthesis in atherosclerosis: too much and not enough. Cardiovas Res 41: 376-384. DOI: 10.1016/S0008-6363(98)00321-6.
15. Robert L, Robert AM, Jacotot B (1998) Elastin-elastase-atherosclerosis revisited. Atherosclerosis 140: 281-295. DOI: 10.1016/S0021-9150898900171-3.
16. Stenina OI, Plow EF (2008) Counterbalancing Forces: What Is Thrombospondin-1 Doing in Atherosclerotic Lesions? Circ Res 103: 1053-1055. DOI: 10.1161/CIRCRESAHA.108.188870.
17. Ait-Oufella H, Taleb S, Mallat Z, Tedgui A (2011) Recent Advances on the Role of Cytokines in Atherosclerosis. Arterioscl Throm Vasc Biol 31: 969-979. DOI: 10.1161/ATVBAHA.110.207415.
18. Robertson A-KL, Hansson GK (2006) T Cells in Atherogenesis: For Better or For Worse? Arterioscl Throm Vasc Biol 26: 2421-2432. DOI: 10.1161/01.ATV.0000245830.29764.84.
19. Lichtman AH, Binder CJ, Tsimikas S, Witztum JL (2013) Adaptive immunity in atherogenesis: new insights and therapeutic approaches. J Clin Invest 123: 27-36. DOI: 10.1172/JCI63108.
20. Duan X, Zhou Y, Teng X, Tang C, Qi Y (2009) Endoplasmic reticulum stress-mediated apoptosis is activated in vascular calcification. Biochem Bioph Res Commun 387: 694-699. DOI: 10.1016/j.bbrc.2009.07.085.
21. Tabas I (2010) The Role of Endoplasmic Reticulum Stress in the Progression of Atherosclerosis. Circ Res 107: 839-850. DOI: 10.1161/CIRCRESAHA.110.224766.
22. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, et al. (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3: research0034. DOI:10.1186/gb-2002-3-7-research0034.11.
23. Hennerici MG (2004) The unstable plaque. Cerebrovas Dis 17: 17-22. DOI: 10.1159/000075300.
24. Virmani R, Burke AP, Farb A, Kolodgie FD (2006) Pathology of the Vulnerable Plaque. J Am Coll Cardiol 47: C13-C18. DOI: 10.1016/j.jacc.2005.10.065.
25. Finn AV, Nakano M, Narula J, Kolodgie FD, Virmani R (2010) Concept of Vulnerable/Unstable Plaque. Arterioscl Throm Vasc Biol 30: 1282-1292. DOI: 10.1161/ATVBAHA.108.179739.
26. Singh R, Kaushik S, Wang Y, Xiang Y, Novak I, et al. (2009) Autophagy regulates lipid metabolism. Nature 458: 1131-1135. DOI: 10.1038/nature07976.
27. Martinez J, Almendinger J, Oberst A, Ness R, Dillon CP, et al. (2011) Microtubule-associated protein 1 light chain 3 alpha (LC3)-associated phagocytosis is required for the efficient clearance of dead cells. Proc Natl Acad Sci USA 108: 17396-17401. DOI: 10.1073/pnas.1113421108.
28. Martinet W, Meyer I, Verheye S, Schrijvers D, Timmermans J P, et al. (2012) Drug-induced macrophage autophagy in atherosclerosis: for better or worse?. Basic Res Cardiol 108: 1-11. DOI: 10.1007/s00395-012-0321-1.
29. Liao X, Sluimer JC, Wang Y, Subramanian M, Brown K, et al. (2012) Macrophage Autophagy Plays a Protective Role in Advanced Atherosclerosis. Cell Metab 15: 545-553. DOI: 10.1016/ j.cmet.2012.01.022.
30. Rouschop KMA, van den Beucken T, Dubois L, Niessen H, Bussink J, et al. (2010) The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5. J Clin Invest 120: 127-141. DOI: 10.1172/JCI40027.
31. Björnheden T, Levin M, Evaldsson M, Wiklund O (1999) Evidence of hypoxic areas within the arterial wall in vivo. Arterioscl Throm Vasc Biol 19: 870-876. DOI: 10.1161/01.ATV.19.4.870.
32. Schrijvers DM, De Meyer GRY, Martinet W (2011) Autophagy in Atherosclerosis: A Potential Drug Target for Plaque Stabilization. Arterioscl Throm Vasc Biol 31: 2787-2791. DOI: 10.1161/ATVBAHA.111.224899.
33. Malaud E, Merle D, Piquer D, Molina L, Salvetat N, et al. (2014) Local carotid atherosclerotic plaque proteins for the identification of circulating biomarkers in coronary patients. Atherosclerosis 233: 551-558. DOI: 10.1016/j.atherosclerosis.2013.12.019
34. de Souza AWS, Westra J, Limburg PC, Bijl M, Kallenberg CGM (2012) HMGB1 in vascular diseases: Its role in vascular inflammation and atherosclerosis. Autoimmun Rev 11: 909-917. DOI: 10.1016/j.autrev.2012.03.007.
35. Hayakawa K, Qiu J, Lo EH (2010) Biphasic actions of HMGB1 signaling in inflammation and recovery after stroke. Ann NY Acad Sci 1207: 50-57. DOI: 10.1111/j.1749-6632.2010.05728.x.
36. Tang D, Kang R, Livesey KM, Cheh CW, Farkas A, et al. (2010) Endogenous HMGB1 regulates autophagy. J Cell Biol 190: 881-892. DOI: 10.1083/jcb.200911078.
37. Munafó DB, Colombo MI (2002) Induction of Autophagy Causes Dramatic Changes in the Subcellular Distribution of GFP-Rab24. Traffic 3: 472-482. DOI: 10.1034/j.1600-0854.2002.30704.x.
38. Wang L, Yu C, Lu Y, He P, Guo J, et al. (2007) TMEM166, a novel transmembrane protein, regulates cell autophagy and apoptosis. Apoptosis 12: 1489-1502. DOI: 10.1007/s10495-007-0073-9.
39. Li L, Khatibi NH, Hu Q, Yan J, Chen C, et al. (2012) Transmembrane protein 166 regulates autophagic and apoptotic activities following focal cerebral ischemic injury in rats. Exp Neurol 234: 181-190. DOI: 10.1016/j.expneurol.2011.12.038.
40. Paschen W (1996) Disturbances of calcium homeostasis within the endoplasmic reticulum may contribute to the development of ischemic-cell damage. Med Hypotheses 47: 283-288. DOI: 10.1016/S0306-9877(96)90068-7.
41. Taylor CW, Genazzani AA, Morris SA (1999) Expression of inositol trisphosphate receptors. Cell Calcium 26: 237-251. DOI: 10.1054/ceca.1999.0090.
42. Decuypere JP, Bultynck G, Parys JB (2011) A dual role for Ca2+ in autophagy regulation. Cell Calcium 50: 242-250. DOI: 10.1016/j.ceca.2011.04.001.
43. Wei K, Wang P, Miao CY (2012) A Double-Edged Sword with Therapeutic Potential: An Updated Role of Autophagy in Ischemic Cerebral Injury. CNS Neurosci Ther 18: 879-886. DOI: 10.1111/cns.12005.
44. Virmani R, Burke AP, Farb A, Kolodgie FD (2006) Pathology of the Vulnerable Plaque. J Am Coll Cardiol 47: C13-C18. DOI: 10.1016/j.jacc.2005.10.065.
45. Di Penta A, Chiba A, Alloza I, Wyssenbach A, Yamamura T, Villoslada P, et al. (2013) A Trifluoromethyl Analogue of Celecoxib Exerts Beneficial Effects in Neuroinflammation. PLoS ONE 8: e83119. DOI: 10.1371/journal.pone.0083119.
46. Mehta TA, Greenman J, Ettelaie C, Venkatasubramaniam A, Chetter IC, et al. (2005) Heat Shock Proteins in Vascular Disease - A Review. Eur J Vasc Endovasc Surg 29: 395-402. DOI: 10.1016/j.ejvs.2005.01.005
47. Hansson GK, Hermansson A (2011) The immune system in atherosclerosis. Nat Immunol 12: 204-212. DOI: 10.1038/ni.2001.
48. Chen S, Crother TR, Arditi M (2010) Emerging Role of IL-17 in Atherosclerosis. J Innate Immun 2: 325-333. DOI: 10.1159/000314626.
49. Taleb S, Romain M, Ramkhelawon B, Uyttenhove C, Pasterkamp G, et al. (2009) Loss of SOCS3 expression in Tcells reveals a regulatory role for interleukin-17 in atherosclerosis. J Exp Med 206: 2067-2077. DOI: 10.1084/jem.20090545.
50. Danzaki K, Matsui Y, Ikesue M, Ohta D, Ito K, et al. (2012) Interleukin-17A Deficiency Accelerates Unstable Atherosclerotic Plaque Formation in Apolipoprotein E-Deficient Mice. Arterioscl Throm Vasc Biol 32: 273-280. DOI: 10.1161/ATVBAHA.111.229997.